[
    "{\"step_by_step_thinking\": \"Tocilizumab (Actemra) is a medication that is used to block the IL-6 receptor. IL-6 is a cytokine that plays a role in inflammation and immune response. Tocilizumab is a monoclonal antibody that specifically targets and binds to the IL-6 receptor, preventing IL-6 from binding and activating the receptor. By blocking the IL-6 receptor, Tocilizumab helps to reduce inflammation and modulate the immune response. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]